The group’s Indian arm, Meyer Vitabiotics, accounts for around 20% of the total Rs 3,000 crore (£253 million) in annual sales. Within Meyer’s portfolio, Calcimax holds a strong presence across paediatrics, diabetes, cardiac care, and women’s health segments, particularly in pregnancy and menopause.
News
Bain Capital sole contender for Vitabiotics buy
April 21, 2026The group’s Indian arm, Meyer Vitabiotics, accounts for around 20% of the total Rs 3,000 crore (£253 million) in annual sales. Within Meyer’s portfolio, Calcimax holds a strong presence across paediatrics, diabetes, cardiac care, and women’s health segments, particularly in pregnancy and menopause.